News
Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
18 Apr 24
Biotech, News, Health Care, Top Stories, General
Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?
25 Mar 24
Biotech, Large Cap, M&A, News, Health Care, Movers, General
Mizuho Maintains Neutral on Cerevel Therapeutics Hldg, Raises Price Target to $45
16 Feb 24
News, Price Target, Analyst Ratings
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
16 Feb 24
Analyst Color, Biotech, Equities, News, Health Care, Price Target, Initiation, Analyst Ratings, Trading Ideas, General
UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst
6 Feb 24
Analyst Color, Biotech, News, Health Care, Price Target, Initiation, Analyst Ratings, Trading Ideas, General
AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall
2 Feb 24
Biotech, Earnings, Large Cap, News, Guidance, Health Care, Movers, General
AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures
29 Jan 24
Analyst Color, Biotech, Equities, Large Cap, News, Upgrades, Health Care, Analyst Ratings, Trading Ideas, General
Press releases
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson's Disease
18 Apr 24
Press Releases
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MGRC, SNCE, VINE, CERE
29 Jan 24
Press Releases
CEREVEL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cerevel Therapeutics - CERE
26 Jan 24
Press Releases